TFF Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • TFF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.54M, a 19.6% increase year-over-year.
  • TFF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$18.5M, a 22.4% increase year-over-year.
  • TFF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$21.2M, a 33.1% increase from 2022.
  • TFF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.8M, a 2.36% decline from 2021.
  • TFF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$31M, a 67.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$21.2M +$10.5M +33.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$31.8M -$731K -2.36% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$31M -$12.5M -67.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$18.6M -$6.7M -56.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$11.9M -$8.03M -209% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 -$3.84M Jan 24, 2018 Dec 31, 2018 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.